| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D | 2019-06-14 | Machado Patrick | Myovant Sciences Ltd. | 40,765,599 | 45.6% | EDGAR |
| SC 13D | 2019-06-14 | Lo Andrew | Myovant Sciences Ltd. | 40,765,599 | 45.6% | EDGAR |
| SC 13D | 2019-06-14 | Dexxon Holdings Ltd. | Myovant Sciences Ltd. | 40,765,599 | 45.6% | EDGAR |
| SC 13D | 2019-06-14 | QVT Financial LP | Myovant Sciences Ltd. | 40,765,599 | 45.6% | EDGAR |
| SC 13D/A | 2019-06-05 | SVF Investments (UK) Ltd | Myovant Sciences Ltd. | 40,765,599 | 45.6% | EDGAR |
| SC 13G/A | 2019-02-14 | Lo Andrew | Myovant Sciences Ltd. | 38,341,357 | 54.2% | EDGAR |
| SC 13G/A | 2019-02-14 | Dexxon Holdings Ltd. | Myovant Sciences Ltd. | 38,341,357 | 54.1% | EDGAR |
| SC 13G/A | 2019-02-14 | QVT Financial LP | Myovant Sciences Ltd. | 38,341,357 | 54.1% | EDGAR |
| SC 13G | 2019-02-14 | RA CAPITAL MANAGEMENT, LLC | Myovant Sciences Ltd. | 3,711,549 | 5.4% | EDGAR |
| SC 13G/A | 2019-02-13 | Roivant Sciences Ltd. | Myovant Sciences Ltd. | 38,341,357 | 54.1% | EDGAR |
| SC 13G/A | 2019-02-13 | Machado Patrick | Myovant Sciences Ltd. | 38,341,357 | 54.1% | EDGAR |
| SC 13G/A | 2019-02-13 | BB BIOTECH AG | Myovant Sciences Ltd. | 3,597,882 | 5.3% | EDGAR |
| SC 13G/A | 2019-01-10 | VIKING GLOBAL INVESTORS LP | Myovant Sciences Ltd. | 38,341,357 | 56.0% | EDGAR |
| SC 13D/A | 2018-04-04 | SVF Investments (UK) Ltd | Myovant Sciences Ltd. | 38,341,357 | 62.9% | EDGAR |
| SC 13G | 2018-03-29 | MILLENNIUM PHARMACEUTICALS INC | Myovant Sciences Ltd. | 7,420,625 | 12.2% | EDGAR |
| SC 13G/A | 2018-02-14 | VIKING GLOBAL INVESTORS LP | Myovant Sciences Ltd. | 37,231,342 | 61.0% | EDGAR |
| SC 13G/A | 2018-02-14 | BB BIOTECH AG | Myovant Sciences Ltd. | 3,507,882 | 5.8% | EDGAR |
| SC 13D | 2017-09-15 | SVF Investments (UK) Ltd | Myovant Sciences Ltd. | 37,231,342 | 61.2% | EDGAR |
| SC 13G | 2017-03-06 | Takeda Pharmaceuticals International AG | Myovant Sciences Ltd. | 7,390,530 | 12.3% | EDGAR |
| SC 13G/A | 2017-02-14 | BB BIOTECH AG | Myovant Sciences Ltd. | 3,192,835 | 5.3% | EDGAR |